Stem Cell Therapy for Multiple Sclerosis Market
Stem Cell Therapy for Multiple Sclerosis Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Stem Cell Therapy for Multiple Sclerosis Market Size and Growth
The Stem Cell Therapy for Multiple Sclerosis market is experiencing significant growth, driven by increasing prevalence of the disease and advancements in treatment options. The market size is projected to reach approximately $X billion by 2030, reflecting robust investment in research and development, alongside rising awareness of innovative therapies among patients.
Companies Covered
(Covid 19 Impact Covered)
◍ American CryoStem
◍ Athersys
◍ Celgene Cellular Therapeutics
◍ Cell Cure Neurosciences
The Stem Cell Therapy for Multiple Sclerosis market is competitive, with companies like American CryoStem, Athersys, Celgene Cellular Therapeutics, and Cell Cure Neurosciences developing innovative therapies. These companies enhance market growth through research advancements and clinical trials. Actual sales revenues include: Athersys: $6 million, Celgene Cellular Therapeutics: $1.5 billion.
Market Segmentation
By Application
◍ Relapsing-Remitting Multiple Sclerosis (RRMS)
◍ Primary Progressive Multiple Sclerosis (PPMS)
◍ Secondary Progressive Multiple Sclerosis (SPMS)
◍ Progressive Relapsing Multiple Sclerosis (PRMS)
By Product
◍ Intravenous ◍ Intracerebroventricular
Market Growth
Request Sample Report
$ 3.43 Billion
